BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-azzawi S, Masheta D. Designing a drug delivery system for improved tumor treatment and targeting by functionalization of a cell-penetrating peptide. J Pharm Investig 2019;49:643-54. [DOI: 10.1007/s40005-018-00424-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Shrestha P, Pathak S, Regmi S, Narayanan KB, Nguyen TT, Yook S, Kim JO, Jeong J. Curcumin-laden ECM-mimicking microfibers assemble with mesenchymal stem cells to generate heterospheroids and enhance cell viability and function. Journal of Industrial and Engineering Chemistry 2022. [DOI: 10.1016/j.jiec.2022.08.036] [Reference Citation Analysis]
2 Duan Q, Shi J, Zhou L, Zhang B, Wang X, Sang S. pH-responsive and sustained release drug delivery system of BSA coated CDs-DOX. Journal of Molecular Structure 2022;1248:131358. [DOI: 10.1016/j.molstruc.2021.131358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
3 Lee J, Hlaing SP, Hasan N, Kwak D, Kim H, Cao J, Yoon IS, Yun H, Jung Y, Yoo JW. Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy. ACS Appl Mater Interfaces 2021;13:30383-96. [PMID: 34162207 DOI: 10.1021/acsami.1c07407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shim MK, Na J, Cho IK, Jang EH, Park J, Lee S, Kim J. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy. Journal of Controlled Release 2021;331:434-42. [DOI: 10.1016/j.jconrel.2021.01.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
5 Singh VK, Singh V, Tyagi V. Recent Update on Nanomedicine-Based Drug Targeting on Colon Cancer. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-64668-4_14] [Reference Citation Analysis]
6 Attri S, Sharma S, Sharma U, Srivastava M, Sonkar SC, Singh M, Bhukya P. Use of Lipids, Polymers, and Peptides for Drug Delivery and Targeting to Cancer Cells or Specific Organs. Handbook of Research on Advancements in Cancer Therapeutics 2021. [DOI: 10.4018/978-1-7998-6530-8.ch008] [Reference Citation Analysis]
7 Khan MM, Filipczak N, Torchilin VP. Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. J Control Release 2021;330:1220-8. [PMID: 33248708 DOI: 10.1016/j.jconrel.2020.11.028] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
8 Kiio TM, Park S. Physical properties of nanoparticles do matter. J Pharm Investig 2021;51:35-51. [DOI: 10.1007/s40005-020-00504-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
9 Yoon HY, Yang HM, Kim CH, Goo YT, Kang MJ, Lee S, Choi YW. Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer. Expert Opinion on Drug Delivery 2020;17:1555-72. [DOI: 10.1080/17425247.2020.1810016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
10 Ramasamy T, Munusamy S, Ruttala HB, Kim JO. Smart Nanocarriers for the Delivery of Nucleic Acid-Based Therapeutics: A Comprehensive Review. Biotechnol J 2021;16:e1900408. [PMID: 32702191 DOI: 10.1002/biot.201900408] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
11 Poudel K, Gautam M, Maharjan S, Jeong JH, Choi HG, Khan GM, Yong CS, Kim JO. Dual stimuli-responsive ursolic acid-embedded nanophytoliposome for targeted antitumor therapy. Int J Pharm 2020;582:119330. [PMID: 32298743 DOI: 10.1016/j.ijpharm.2020.119330] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
12 Phung CD, Tran TH, Kim JO. Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review. Arch Pharm Res 2020;43:32-45. [DOI: 10.1007/s12272-020-01218-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
13 Lamichhane S, Lee S. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy. Arch Pharm Res 2020;43:118-33. [PMID: 31916145 DOI: 10.1007/s12272-020-01204-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
14 Lim C, Won WR, Moon J, Sim T, Shin Y, Kim JC, Lee ES, Youn YS, Oh KT. Co-delivery of d -(KLAKLAK) 2 peptide and doxorubicin using a pH-sensitive nanocarrier for synergistic anticancer treatment. J Mater Chem B 2019;7:4299-308. [DOI: 10.1039/c9tb00741e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]